


Healthcare Industry News: HIV/AIDS
News Release - June 27, 2019
OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers
Source: OncoSec Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
